Table of Contents

December 1, 2014; Volume 55,Issue 12

  1. Able, Sarah

    1. Imaging DNA Damage Allows Detection of Preneoplasia in the BALB-neuT Model of Breast Cancer
      Bart Cornelissen, Sarah Able, Christiana Kartsonaki, Veerle Kersemans, P. Danny Allen, Federica Cavallo, Jean-Baptiste Cazier, Manuela Iezzi, James Knight, Ruth Muschel, Sean Smart and Katherine A. Vallis
      Journal of Nuclear Medicine December 1, 2014, 55 (12) 2026-2031; DOI: https://doi.org/10.2967/jnumed.114.142083

  2. Adams, Christopher T.

    1. The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts
      Carol A. Nelson, Michael T. Azure, Christopher T. Adams and Kurt R. Zinn
      Journal of Nuclear Medicine December 1, 2014, 55 (12) 2020-2025; DOI: https://doi.org/10.2967/jnumed.114.140780

  3. Adamsen, Dea

    1. In Vivo Quantification of Cerebral Translocator Protein Binding in Humans Using 6-Chloro-2-(4′-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamide SPECT
      Ling Feng, Claus Svarer, Gerda Thomsen, Robin de Nijs, Vibeke A. Larsen, Per Jensen, Dea Adamsen, Agnete Dyssegaard, Walter Fischer, Per Meden, Derk Krieger, Kirsten Møller, Gitte M. Knudsen and Lars H. Pinborg
      Journal of Nuclear Medicine December 1, 2014, 55 (12) 1966-1972; DOI: https://doi.org/10.2967/jnumed.114.143727

  4. Akudugu, John M.

    1. The Advantage of Antibody Cocktails for Targeted Alpha Therapy Depends on Specific Activity
      Jordan B. Pasternack, Jason D. Domogauer, Alisha Khullar, John M. Akudugu and Roger W. Howell
      Journal of Nuclear Medicine December 1, 2014, 55 (12) 2012-2019; DOI: https://doi.org/10.2967/jnumed.114.141580

  5. Allen, P. Danny

    1. Imaging DNA Damage Allows Detection of Preneoplasia in the BALB-neuT Model of Breast Cancer
      Bart Cornelissen, Sarah Able, Christiana Kartsonaki, Veerle Kersemans, P. Danny Allen, Federica Cavallo, Jean-Baptiste Cazier, Manuela Iezzi, James Knight, Ruth Muschel, Sean Smart and Katherine A. Vallis
      Journal of Nuclear Medicine December 1, 2014, 55 (12) 2026-2031; DOI: https://doi.org/10.2967/jnumed.114.142083

  6. Allen-auerbach, Martin S.

    1. Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians
      Dimitrios Karantanis, Dimitrios Kalkanis, Johannes Czernin, Ken Herrmann, Kelsey L. Pomykala, Trond V. Bogsrud, Rathan M. Subramaniam, Val J. Lowe and Martin S. Allen-Auerbach
      Journal of Nuclear Medicine December 1, 2014, 55 (12) 1925-1929; DOI: https://doi.org/10.2967/jnumed.114.145607

  7. Auewarakul, Chirayu

    1. Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma
      Robert Carr, Stefano Fanti, Diana Paez, Juliano Cerci, Tamás Györke, Francisca Redondo, Tim P. Morris, Claudio Meneghetti, Chirayu Auewarakul, Reena Nair, Charity Gorospe, June-Key Chung, Isinsu Kuzu, Monica Celli, Sumeet Gujral, Rose Ann Padua, Maurizio Dondi and the IAEA Lymphoma Study Group
      Journal of Nuclear Medicine December 1, 2014, 55 (12) 1936-1944; DOI: https://doi.org/10.2967/jnumed.114.145326

  8. Azure, Michael T.

    1. The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts
      Carol A. Nelson, Michael T. Azure, Christopher T. Adams and Kurt R. Zinn
      Journal of Nuclear Medicine December 1, 2014, 55 (12) 2020-2025; DOI: https://doi.org/10.2967/jnumed.114.140780
Back to top

In this issue